Estimación del riesgo cardiovascular según el algoritmo de Framingham en sujetos con síndrome metabólico, definido por los criterios del NCEP-ATP-III

Application of the Framingham score to determine 10-year risk for CHD in the population studied revealed that most subjects had a low risk (> 80%). No significant differences were found between men and women with and without MS in different risk categories. However, certain studies have demonstrated that Framingham scoring and the ATP-III-NCEP underestimate risk in women, mainly in those with a history of premature CHD or MS. Therefore, other tools should be used to predict cardiovascular risk with greater reliability.